Survival Analysis of Sudanese Oral Squamous Cell Carcinoma Patients with Field of Cancerization

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2024 Apr 15

PMID 38622532

Authors

Yousif Eltohami

Ahmed Suleiman

Affiliations

Soon will be listed here.

Abstract

Background: The late presentation and diagnosis of OSCC account for the large number of patients with the advanced form of the disease. In Sudan, cases with delayed presentation, particularly those with risk factors such as Toombak dipping and alcohol consumption, frequently present with extensive lesions and a wide area of Field cancerization which characterized by the presence of genetic and epigenetic changes in histologically normal-appearing tissues, and have increased risk for recurrent and second primary tumors. This necessitates more aggressive treatment and is usually associated with poorer outcomes. The present study aims to investigate the survival of oral squamous cell carcinoma patients with a wide field of cancerization.

Methods: This prospective longitudinal study includes ninety-three oral cancer patients with extensive fields of cancerization who underwent surgical treatment at Khartoum Teaching Dental Hospital (KTDH) conducted from 2019 to 2023. These patients were regularly assessed for clinical changes such as recurrence, the development of second primary tumours, and overall survival over a period of one year.

Results: Out of the 93 patients, 57 (61.3%) were males, and 36 (38.7%) were females. The majority of the patients (82%) had stage IV tumours, and 62.3% had nodal metastasis. Twenty-eight (30%) patients developed recurrences, and 14 (15%) developed second primary tumours. The overall one-year survival rate was 89%, and all deceased patients passed away within 12 months. The survival rate for patients with different types of recurrences varied, with patients who had regional, local, and locoregional recurrences having survival rates of 87%, 74%, and 72%, respectively. Patients who did not experience a recurrence had a one-year survival rate of 92%. Patients who developed second primary tumours had an 86% survival rate. The survival rates for OSCC patients at stages III, IVa, and IVb were 90%, 90%, and 71%, respectively.

Conclusion: In this study, 62% of patients had nodal metastasis, 30% developed recurrence, and 15% developed second primary tumours. The overall one-year survival rate was 89%, although the development of recurrences and second primary tumours had a negative impact on the survival rate.

Citing Articles

Recurrence of oral squamous cell carcinoma in surgically treated patients at Khartoum Teaching Dental Hospital retrospective cross-sectional study.

Alim N, Elsheikh M, Satti A, Tabassum N, Suleiman A BMC Cancer. 2024; 24(1):781.

PMID: 38943108 PMC: 11214227. DOI: 10.1186/s12885-024-12562-6.

References

Gondos A, Bray F, Brewster D, Coebergh J, Hakulinen T, Janssen-Heijnen M . Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries. Eur J Cancer. 2008; 44(10):1463-75. DOI: 10.1016/j.ejca.2008.03.010. View

Le Campion A, Ribeiro C, Luiz R, da Silva Junior F, Barros H, Dos Santos K . Low Survival Rates of Oral and Oropharyngeal Squamous Cell Carcinoma. Int J Dent. 2017; 2017:5815493. PMC: 5468590. DOI: 10.1155/2017/5815493. View

Warnakulasuriya S . Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2008; 45(4-5):309-16. DOI: 10.1016/j.oraloncology.2008.06.002. View

Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2011; 127(12):2893-917. DOI: 10.1002/ijc.25516. View

Liao C, Chang J, Wang H, Ng S, Hsueh C, Lee L . Salvage therapy in relapsed squamous cell carcinoma of the oral cavity: how and when?. Cancer. 2007; 112(1):94-103. DOI: 10.1002/cncr.23142. View

Eltohami Y, Sulaiman A . Recurrence in Oral Squamous Cell Carcinoma Associated with Wide Field of Cancerization: Analysis of 93 Cases. Indian J Otolaryngol Head Neck Surg. 2023; 75(3):1329-1335. PMC: 10447784. DOI: 10.1007/s12070-023-03548-0. View

Anderson C, Sisson K, Moncrieff M . A meta-analysis of margin size and local recurrence in oral squamous cell carcinoma. Oral Oncol. 2015; 51(5):464-9. DOI: 10.1016/j.oraloncology.2015.01.015. View

Priya S, DCruz A, Pai P . Cut margins and disease control in oral cancers. J Cancer Res Ther. 2012; 8(1):74-9. DOI: 10.4103/0973-1482.95178. View

Shetty K, Kurle V, Greeshma P, Ganga V, Murthy S, Thammaiah S . Salvage Surgery in Recurrent Oral Squamous Cell Carcinoma. Front Oral Health. 2022; 2:815606. PMC: 8831824. DOI: 10.3389/froh.2021.815606. View

10.

Cianfriglia F, Di Gregorio D, Manieri A . Multiple primary tumours in patients with oral squamous cell carcinoma. Oral Oncol. 1999; 35(2):157-63. DOI: 10.1016/s1368-8375(98)00105-5. View

11.

Jain P, Sharan R, Manikantan K, Clark G, Chatterjee S, Mallick I . Redefining adequate margins in oral squamous cell carcinoma: outcomes from close and positive margins. Eur Arch Otorhinolaryngol. 2020; 277(4):1155-1165. DOI: 10.1007/s00405-019-05779-w. View

12.

Wang B, Zhang S, Yue K, Wang X . The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases. Chin J Cancer. 2013; 32(11):614-8. PMC: 3845544. DOI: 10.5732/cjc.012.10219. View

13.

Vartanian J, Carvalho A, Yueh B, Priante A, Melo R, Correia L . Long-term quality-of-life evaluation after head and neck cancer treatment in a developing country. Arch Otolaryngol Head Neck Surg. 2004; 130(10):1209-13. DOI: 10.1001/archotol.130.10.1209. View

14.

Sousa A, Caldeira P, da Silva K, de Aguiar M, Faria D, de Moraes G . Survival analysis of recurrent squamous cell carcinoma of the lower oral cavity treated by surgery. Int J Clin Exp Pathol. 2021; 14(6):713-719. PMC: 8255197. View

15.

Howlader N, Ries L, Mariotto A, Reichman M, Ruhl J, Cronin K . Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst. 2010; 102(20):1584-98. PMC: 2957430. DOI: 10.1093/jnci/djq366. View

16.

Guerra M, Naval Gias L, Campo F, Perez J . Marginal and segmental mandibulectomy in patients with oral cancer: a statistical analysis of 106 cases. J Oral Maxillofac Surg. 2003; 61(11):1289-96. DOI: 10.1016/s0278-2391(03)00730-4. View

17.

Tsou Y, Hua C, Tseng H, Lin M, Tsai M . Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma. Acta Otolaryngol. 2007; 127(6):651-7. DOI: 10.1080/00016480600951517. View

18.

Schwartz L, Ozsahin M, Zhang G, Touboul E, De Vataire F, Andolenko P . Synchronous and metachronous head and neck carcinomas. Cancer. 1994; 74(7):1933-8. DOI: 10.1002/1097-0142(19941001)74:7<1933::aid-cncr2820740718>3.0.co;2-x. View

19.

Leon X, Venegas M, Orus C, Kolanczak K, Garcia J, Quer M . Metachronous second primary tumours in the aerodigestive tract in patients with early stage head and neck squamous cell carcinomas. Eur Arch Otorhinolaryngol. 2005; 262(11):905-9. DOI: 10.1007/s00405-005-0922-5. View

20.

van der Haring I, Schaapveld M, Roodenburg J, de Bock G . Second primary tumours after a squamous cell carcinoma of the oral cavity or oropharynx using the cumulative incidence method. Int J Oral Maxillofac Surg. 2009; 38(4):332-8. DOI: 10.1016/j.ijom.2008.12.015. View